The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.
- Trial number:
-
NCT04093401
- Trial phase:
- N/A
- Study type:
- Observational, Supportive interventions
- Overall status:
- Recruiting
Study start date
June, 2021
Scientific title
An Open-Label, Single Blind Study of How Knowledge of Risk of Subsequent Basal Cell Carcinoma Affects Compliance With Requested Follow-Up in Patients With First Basal Cell Carcinoma
Summary
While current guidelines call for annual follow-up for patients with a history of basal cell
carcinoma, compliance with these guidelines is imperfect. It is hypothesized that if patients
are informed of the quantitative risk of a subsequent basal cell carcinoma based on
individualized risk factors, the compliance rate for follow-up will improve.
The primary objective of this study is to assess one-year compliance with requested follow-up
for patients with recent history of basal cell carcinoma, among those who receive standard
sun avoidance counseling and request for follow-up compared to those who receive, in
addition, an estimate of their mathematical risk of a subsequent basal cell carcinoma based
on individualized risk factors.
- Age 18 years or older - Diagnosed with at least one Basal Cell Carcinoma within 30 days prior to enrollment - Able and willing to answer all questions accurately in the Individualized Risk Assessment
- History of Basal Cell Carcinoma 31 or more days prior to enrollment - Solid Organ Transplant Recipient - History of Immunodeficiency (e.g., HIV infection, AIDS, genetic immunodeficiency - Prisoner - Psychiatric inpatients or people who are institutionalized
Study design
Primary purpose:
Supportive Care,
Allocation:
Randomized,
Intervention model:
Parallel Assignment,
Masking:
Single,
Subject masked:
Yes,
Conditions
Basal Cell Carcinoma
Other study ID numbers
UW19002; 2019-0077; A534300; SMPH/DERMATOLOGY/DERMATOLOG